14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ICPT
Powered by GPT-4
Stock Analysis
Risk Assessment
Trading Strategy

Intercept Pharmaceuticals stock price ended on $19.00 on Friday after losing 0%
(Updated on Dec 08, 2023)

Buy or Hold candidate since Sep 27, 2023 Gain 2.26% PDF
No changes to the price of Intercept Pharmaceuticals stock on the last trading day (Friday, 8th Dec 2023). During the last trading day the stock fluctuated 0% from a day low at $19.00 to a day high of $19.00. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 40.96% during the next 3 months and, with a 90% probability hold a price between $22.75 and $32.85 at the end of this 3-month period.

ICPT Signals & Forecast

The Intercept Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.00 and $18.96. A breakdown below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, December 07, 2023, and so far it has fallen 0%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.

Special Signal Notification

Double Top Formation

Double Top Formation

Maximize Your Market Edge: Go Premium for In-Depth AI-Powered Stock Research and Exclusive Lists! 🚀

Support, Risk & Stop-loss for Intercept Pharmaceuticals stock

Intercept Pharmaceuticals finds support from accumulated volume at $18.71 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%

Our recommended stop-loss: $18.24 (-4.00%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (ICPT) For The Upcoming Trading Day Of Monday 11th

For the upcoming trading day on Monday, 11th we expect Intercept Pharmaceuticals to open at $19.00, and during the day (based on 14 day Average True Range), to move between $18.95 and $19.05, which gives a possible trading interval of +/-$0.0477 (+/-0.25%) up or down from last closing price. If Intercept Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 0.50% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $18.71, some $0.290 (1.53%) from the current price of $19.00, our system finds the risk reward attractive.

Is Intercept Pharmaceuticals stock A Buy?

Intercept Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.000 Open Broker Account

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Hold/Accumulate Unchanged

Predicted Opening Price for Intercept Pharmaceuticals of Monday, December 11, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 11, 2023 Current price
$19.00 $19.00 (Undervalued)

Remember To Visit Our YouTube Channel

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 19.00 .
R2 19.00 .
R1 19.00 .
Current price: 19.00
Support S1 19.00 .
S2 19.00 .
S3 19.00 .

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 19.00
Support S1 18.71 -1.53%
S2 18.58 -2.21%
S3 18.20 -4.21%
What is the symbol for Intercept Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Intercept Pharmaceuticals is ICPT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Intercept Pharmaceuticals Stock?
Intercept Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Intercept Pharmaceuticals Stock?
Intercept Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Intercept Pharmaceuticals Stock.

What's the current price of Intercept Pharmaceuticals Stock?
As of the end of day on the 2023-12-08, the price of an Intercept Pharmaceuticals (ICPT) share was $19.00.

What is the 52-week high and low for Intercept Pharmaceuticals Stock?
The 52-week high for Intercept Pharmaceuticals Stock is $21.86 and the 52-week low is $8.82.

What is the market capitalization of Intercept Pharmaceuticals Stock?
As of the 2023-12-08, the market capitalization of Intercept Pharmaceuticals is 794.694M.

When is the next earnings date for Intercept Pharmaceuticals?
The upcoming earnings date for Intercept Pharmaceuticals is 2024-03-07 00:00:00.

Click to get the best stock tips daily for free!

About Intercept Pharmaceuticals

Intercept Pharmaceuticals Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination with ursodeoxycholic acid in adults. It is also developing Ocaliva for various indications, including nona... ICPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE